The abstract is read at the publisher; the summary is JClub's.
Metastatic cancer cell dormancy in disseminated cancer cells is linked to cancer relapse, with microenvironmental, epigenetic, immune-evasion, and translation-limiting mechanisms shaping reactivation.
- Why it matters: Dormant disseminated cells persist before reactivating, making relapse a key challenge and leaving clinical translation constrained by insufficiently implemented dormancy biomarkers or therapies.
- What they did: This Review synthesizes advances on niche-derived signals, extracellular matrix composition, epigenetic/transcriptional programs, chromatin remodeling, and innate and adaptive immune interactions, including residual cells in haematologic malignancies.
- The result: The integrated dormancy framework highlights challenges and opportunities for leveraging dormancy biology to prevent metastatic recurrence and improve patient outcomes, though effective clinical implementation remains limited.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.